



Investor Resources
Reasons to Invest in Our Company
| |
· Company’s proprietary
software and improved prescription handling process provides
digiMedical a
competitive edge over competitive business models.
|
| |
First year revenue of $7-10M, forecasted growth of 23% per
year, representing a substantial ROI opportunity.
|
| |
Constantly working to increase market share through organic
growth as well as the acquisition of independent pharmacy
chains in strategic markets
|
| |
· Six pharmacies and more than
35,000 customers currently using
digiRX™
system
|
| |
· Microsoft
Independent Solutions Vendor (ISV)
|
Financial Statements
CHECK BACK FOR UPDATED FINANCIALS
Other Resources
- Stock Quote
- Yahoo Profile
- Market Makers (Non reporting)
- 10-KSB Annual Report (Non reporting)